EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Phosphoproteomic dysregulation promotes tumor proliferation in Cushing’s disease

David T Asuzu iD, Dhruval Bhatt, Dustin Mullaney iD, Debjani Mandal iD, Diana Nwokoye, Sheelu Varghese iD, Daniela Tortoza Lopez, Nikhil Ramavenkat, Kory Johnson iD, Abdel G Elkahloun, Zied Abdullaev iD, Kenneth Aldape und 9 weitere

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2528513123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von David T Asuzu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Neurosurgery Unit for Pituitary and Inheritable Diseases, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892. Hauptthemen laut MEDLINE: Pituitary ACTH Hypersecretion, Phosphoproteins, Pituitary Neoplasms, Adenoma. Die Arbeit nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Intramural NIH HHS, HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pituitary adenomas constitute up to 20% of primary brain tumors, yet somatic mutations are only found in 15% of pituitary adenomas. Epigenomic dysregulation has been proposed as a tumorigenic mechanism in pituitary adenomas causing Cushing’s disease (CD). We created paired datasets of human CD adenomas and en-route margin adult human pituitary glands, and assayed their chromatin accessibility, DNA methylation, transcriptomic, proteomic, and phospho-proteomic landscapes. In CD adenomas, we found epigenetic reactivation of a neurodevelopmental phosphoprotein program typically lost in the postnatal pituitary gland. CD cells overexpressed PPP1R17 , an endogenous inhibitor of the protein phosphatase PP2A. Mechanistically, PPP1R17 overexpression in normal murine pituitary cells recapitulated the adenoma phenotype, and the resulting hyperproliferation was reversed in a PP2A-dependent manner by fingolimod, an FDA-approved small molecule, both in vitro and in vivo. Our findings highlight kinase-phosphatase imbalance as a targetable mechanism in CD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary ACTH HypersecretionPhosphoproteinsPituitary NeoplasmsAdenomaHumansAnimalsCell ProliferationMiceProteomicsProtein Phosphatase 2Epigenesis, GeneticDNA MethylationProteomeGene Expression Regulation, NeoplasticPituitary Gland

Stichwörter der Autor:innen

Cushing’s diseaseepigenomicsmultiomephosphoproteomepituitary adenomas

Substanzen

PhosphoproteinsProtein Phosphatase 2Proteome

Autor:innen und Institutionen

  • Neurosurgery Unit for Pituitary and Inheritable Diseases, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892.
  • Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892.
  • Department of Neurological Surgery, University of Virginia, Charlottesville, VA 22903.
  • Department of Neurosurgery, University of Texas Southwestern, Dallas, TX 75231.
  • Division of Intramural Research, Bioinformatics Section, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892.
  • Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, Bethesda, MD20892.

ORCID-Profile: David T Asuzu, Dustin Mullaney, Debjani Mandal, Sheelu Varghese, Kory Johnson, Zied Abdullaev, Dragan Maric, Clarisse Quignon, Yan Li, Susan Wray, Lynnette K Nieman, Prashant Chittiboina

Förderung

  • Intramural NIH HHS
  • HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)

Zitieren

APA

Asuzu, D. T., Bhatt, D., Mullaney, D., Mandal, D., Nwokoye, D., Varghese, S., Tortoza Lopez, D., Ramavenkat, N., Johnson, K., Elkahloun, A. G., Abdullaev, Z., Aldape, K., Maric, D., Quignon, C., Malik, N., Steiner, J. P., Li, Y., Wray, S., Tatsi, C., …, & Chittiboina, P. (2026). Phosphoproteomic dysregulation promotes tumor proliferation in Cushing’s disease. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2528513123

Vancouver

Asuzu DT, Bhatt D, Mullaney D, Mandal D, Nwokoye D, Varghese S, et al. Phosphoproteomic dysregulation promotes tumor proliferation in Cushing’s disease. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2528513123

BibTeX
@article{Asuzu2026,
  author = {Asuzu, David T and Bhatt, Dhruval and Mullaney, Dustin and Mandal, Debjani and Nwokoye, Diana and Varghese, Sheelu and Tortoza Lopez, Daniela and Ramavenkat, Nikhil and Johnson, Kory and Elkahloun, Abdel G and Abdullaev, Zied and Aldape, Kenneth and Maric, Dragan and Quignon, Clarisse and Malik, Nasir and Steiner, Joseph P and Li, Yan and Wray, Susan and Tatsi, Christina and Nieman, Lynnette K and Chittiboina, Prashant},
  title = {Phosphoproteomic dysregulation promotes tumor proliferation in Cushing’s disease},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2528513123}
}
Kostenlos starten →